Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
founded date
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Similar Companies1000
Inozyme
Inozyme is developing novel therapeutics for the treatment of diseases of abnormal mineralization.
Sector
Subsector
Keywords
Location
total rounds
total raised
Complexa
Complexa is a biopharmaceutical company that develops therapies for inflammatory and metabolic diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
Cullgen
Cullgen is a biopharmaceutical company that develops protein degradation technology.
Sector
Subsector
Keywords
Location
total rounds
total raised
Amplyx Pharmaceuticals
Amplyx Pharmaceuticals is developing innovative therapies for life-threatening diseases affecting people with compromised immune systems.
Sector
Subsector
Location
total rounds
total raised
M&A Details1
Financials
Funding Rounds14
Number of Funding Rounds
Money Raised
Their latest funding was raised on 01.07.2020. Their latest round Post-IPO Equity
Co-Investors
Investors13
Number of lead investors
Number of investors
Jerusalem Global Ventures
Jerusalem Global Ventures is an Israeli Investment Firm that funds technology startups.
Sector
Subsector
Keywords
Location
total rounds
total raised
count Of Investments
count Of Exists
Yissum Technology Transfer Company of the Hebrew University
Yissum is a leading tech transfer company commercializing innovations from Hebrew University.
Sector
Subsector
Location
count Of Investments
count Of Exists
F2 Ventures
F2 Ventures is a venture capital and private equity firm focused on investing in the biotechnology sector.
Sector
Subsector
Location
count Of Investments
count Of Exists
Bard Geesaman
Dr. Bard Geesaman serves as Managing Director at MPM Capital. Dr. Geesaman served on the Board of Directors at Chiasma. He serves as Board Member at Genascence. He previously served as Board Member at Maverick Therapeutics. He served as a Board Member at ProterixBio. He served as a Board Member of iOmx Therapeutics. He has been with MPM and associated portfolio companies since 2002. He has broad experience investing, operating, and facilitating business development globally, including in Japan, China, and Israel. Prior to joining MPM, he founded Catalyst Medical Solutions, a medical documentation and billing eHealth company in Boston where he served as the Chief Technology Officer through the company's acquisition. After Catalyst, he joined Centagenetix, an MPM-founded company exploring the genetics of successful aging. He received a B.S. in neuroscience from U.C. Berkeley followed by concurrent degrees from Harvard Medical School and M.I.T. with his Ph.D. work focused on systems and computational neurobiology. He finished his medical training by completing a three-year medical residency at Massachusetts General Hospital. [Source: Public Company Filing]
current job
organization founded
People
Employee Profiles17
David Plante
Vice president, information technology